42. Construct Validity –
Introducing a similar physiological / neural mechanism
of inducing the disorder as in the human disorder.
Pharmacological Validity –
Drugs that are effective in humans are effective in reducing
symptoms in the model.
Face or Ecological Validity –
The set of symptoms in the animal model
holds great resemblance to the human disorder
Validating an animal model of a PTSD
43. Construct Validity –
Introducing a similar physiological / neural mechanism
of inducing the disorder as in the human disorder.
Pharmacological Validity –
Drugs that are effective in humans are effective in reducing
symptoms in the model.
Face or Ecological Validity –
The set of symptoms in the animal model
holds great resemblance to the human disorder
Validating an animal model of a PTSD
44. Construct Validity –
Introducing a similar physiological / neural mechanism
of inducing the disorder as in the human disorder.
Pharmacological Validity –
Drugs that are effective in humans are effective in reducing
symptoms in the model.
Face or Ecological Validity –
The set of symptoms in the animal model
holds great resemblance to the human disorder
Validating an animal model of a PTSD
51. Behavioral testing
The Under Water Trauma (UWT) –
A model of a brief, intense traumatic experience
which is ecologically relevant to both humans and rats
60. Exposed to a traumatic event
most people DO NOT develop
Post-traumatic stress disorder
61. The exposure to the traumatic experience is necessary,
but not a sufficient condition to induce the disorder.
There must be additional factors that
determine the outcome of the exposure
to the trauma.
65. Effects of the UWT one month after exposure
With or without a history of juvenile stress
cm
*
*
Activity Anxiety Index
(Ardi et al. Neurobiol. Dis. 2016)
66. Effects of the UWT one month after exposure
With or without a history of juvenile stress
McLaughlin et al., Psychol. Med., 2010
PTSD
Number of past year major stressful events
12-monthprevalence
Increased prevalence to PTSD
upon trauma later in life by
Childhood adversity
67. • A brief, acute and intense, ecologically relevant trauma
• Tested a long time (one month) after the exposure (PTSD)
• Effects intensified by presentation of a reminder of the original trauma!
• Risk factors that contribute to developing PTSD also promote symptoms
in this model.
• Individual differences are taken into consideration.
Towards a relevant drug testing platform for PTSD
69. PTSD scale 6 month later
0
10
20
30
40
50
Group A Group B
PTSD symptoms
0
10
20
30
40
50
60
70
80
90
100
0.5 1 1.5 2 2.5
Group A Group B
** Pychiatric criteria
70.
71. Can we Increase translational power of the animal
model by addressing individual differences
72. PND 64
±
±
1 month
Underwater trauma
(UWT) ± odor
ControlUWT(-)UWT(+)
“affected” = - 1 SD / + 1
SD from mean of
Control in
5 of 6 measurements
Behavioral Profiling
80. Gender differences in the prevalence of ICD-10 PTSD
PETERS et al, Psychological Medicine (2006), 36:1:81-89
The pattern of gender difference at the diagnostic level was mirrored in the
pattern of gender differences at the criterion level for both DSM-IV and ICD-
10.
Females only endorsed three symptoms at a significantly higher rate
than males. For all other symptoms, endorsement was equal.
This apparently small gender difference at the symptom level was
sufficient to cause the gender difference at the diagnostic level for ICD-
10.
Potential gender differences?
84. Two way Shuttle Avoidance
=
=
Juvenile stressed
Female rats
do not exhibit
Significant impairment
in the Two way Shuttle
Avoidance task!
Horovitz et al, 2014
90. Summary and Conclusions:
• There is still no effective treatment to stress-related
psychopathologies.
• Novel approaches developed in recent
years bring hope that soon we will be able
to develop better ways to treat stress
and stress-related psychopathologies.
91. The sex differences in symptoms and in neural mechanisms
require separate diagnosis criteria -
Gender difference:
97. Thank You
University of Haifa
Prof. Mouna Maroun
Prof. Irit Akirav
Dr. Hanoch Kaphzan
Tel Aviv University
Dr. Segev Barak
The Weizmann Institute , Israel
Prof. Menahem Segal
Institute of Biology, Magdeburg, Germany
Iris Müller
Prof. Oliver Stork
Natural and Medical Sciences Institute (NMI),
Universität Tübingen
Dr. Martin Kriebel,
Prof. Hansjürgen Volkmer
Funding Agencies:
Israel Science Foundation (ISF)
Israel Ministry of Science and Technology (MOST)
Programme of German-Israeli Project Cooperation (DIP)
German Research Foundation (DFG)
Department of Defense, USA (DoD)
Chinese Academy of Science
Prof. Lin Xu
East China Normal University (ECNU)
Prof. Xiahoua Cau